List of Morphic Therapeutic patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11040955 Inhibitors of (alpha-v)(beta-6) integrin	Patent 11040955 was granted and assigned to Morphic Therapeutic on June, 2021 by the United States Patent and Trademark Office.	Morphic Therapeutic	Morphic Therapeutic	United States Patent and Trademark Office	11040955	June 22, 2021
‌ US Patent 11046669 Inhibitors of (α-v)(β-6) integrin	Patent 11046669 was granted and assigned to Morphic Therapeutic on June, 2021 by the United States Patent and Trademark Office.	Morphic Therapeutic	Morphic Therapeutic	United States Patent and Trademark Office	11046669	June 29, 2021
‌ US Patent 11370773 Inhibiting human integrin (alpha-4) (beta-7)	Patent 11370773 was granted and assigned to Morphic Therapeutic on June, 2022 by the United States Patent and Trademark Office.	Morphic Therapeutic	Morphic Therapeutic	United States Patent and Trademark Office	11370773	June 28, 2022
‌ US Patent 11046685 Inhibitors of (α-v)(β-6) integrin	Patent 11046685 was granted and assigned to Morphic Therapeutic on June, 2021 by the United States Patent and Trademark Office.	Morphic Therapeutic	Morphic Therapeutic	United States Patent and Trademark Office	11046685	June 29, 2021
‌ US Patent 10759756 Antagonists of human integrin α4β7		Morphic Therapeutic	Morphic Therapeutic	United States Patent and Trademark Office	10759756	September 1, 2020
‌ US Patent 11174228 Antagonists of human integrin (α4)(β7)	Patent 11174228 was granted and assigned to Morphic Therapeutic on November, 2021 by the United States Patent and Trademark Office.	Morphic Therapeutic	Morphic Therapeutic	United States Patent and Trademark Office	11174228	November 16, 2021
‌ US Patent 11021480 Inhibiting (α-V)(β-6) integrin	Patent 11021480 was granted and assigned to Morphic Therapeutic on June, 2021 by the United States Patent and Trademark Office.	Morphic Therapeutic	Morphic Therapeutic	United States Patent and Trademark Office	11021480	June 1, 2021
‌ US Patent 11104661 Inhibiting human integrin (α-4) (β-7)	Patent 11104661 was granted and assigned to Morphic Therapeutic on August, 2021 by the United States Patent and Trademark Office.	Morphic Therapeutic	Morphic Therapeutic	United States Patent and Trademark Office	11104661	August 31, 2021